Quick Heal Technologies LtdQ4 FY26
Quick Heal Technologies Ltd Q4 FY26 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹140Market Cap: ₹830 CrSector: IT - Software
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
N/A
Order
Yes
Capex
N/A
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- →Quick Heal anticipates the enterprise vertical to be the primary growth driver over the next 2-3 years, targeting it to comprise 80-90% of revenue.
- →Enterprise business showed consistent growth, especially in government and BFSI segments, supported by increased deferred revenue and a strong order book.
- →Strategic investments are being made to expand in South East Asia, Middle East, Africa, and Latin America.
- →Cloud adoption in security solutions is increasing rapidly, now contributing 40% to EPP and EDR deployments, up from 20% two years ago.
- →New offerings like Digital Risk Protection Services (DRPS), Ransomware Recovery as a Service (RRAS), and data privacy solutions are expected to gain traction with increased regulatory compliance needs.
- →Consumer business continues to face headwinds with expected short-term pressures; however, leadership in this segment is maintained.
- →Overall, the company sees a transitionary phase with growth resuming post two quarters, backed by investments in AI, product innovation, and market expansion.
Margin guidance
Category 3- →Quick Heal is undergoing a transition from a B2C antivirus to a holistic cybersecurity company, focusing on enterprise business.
- →Enterprise vertical now represents over 50% of revenue, expected to grow to 80-90% within 2-3 years (Ankit Maheshwari & Kailash Katkar).
- →Consumer business faces headwinds, with revenues expected to face some short-term pressure, especially in next 1-2 quarters.
- →EBITDA and PAT turned negative due to revenue decline and fixed cost structure; however, management expects this phase to last a maximum of two quarters.
- →Investments in AI, data privacy, and cloud security are key growth drivers supporting future profitability.
- →Revenue growth is anticipated from new products like EDR, XDR, DRPS, ransomware recovery, and data privacy solutions.
- →The company maintains a strong, debt-free balance sheet, allowing continued R&D and market expansion.
- →Overall, management is confident of sustainable growth and profitability in the medium term despite near-term challenges.
3 more insights locked — sign up free to unlock
Fundraise plans
- →The company currently has a strong and debt-free balance sheet, providing flexibility for investments.
- →There is no mention of any new fundraising plans through debt or equity in the call.
- →Focus remains on investing in R&D and market expansion using existing cash and investments.
- →Cash and investments stood at Rs. 249 crores as of the latest update.
- →Management did not indicate any intent or plan to raise external capital at this stage.
Order book
Yes- →Current order book stands at Rs. 55 crores for FY’26, up from Rs. 6 crores in FY’25.
- →Deferred revenue increased to Rs. 34 crores from Rs. 14 crores in the previous year.
- →Successfully executed a cyber literacy order received in February 2025.
- →Secured an additional order worth Rs. 64 crores related to the implementation of integrated cybersecurity solutions.
- →The order book reflects strong confidence in the company's transformation into a holistic cybersecurity solutions provider.
- →Growth driven largely by robust momentum in the government segment.
Capex plans
- →The company continues to invest significantly in R&D, fully expensing these investments in the year incurred.
- →Strategic investments have been made in expanding market presence in South East Asia, Middle East Africa, and Latin America.
- →Investment focus on AI-driven technologies, threat intelligence, data privacy, and scalable global capabilities to stay ahead in the cybersecurity industry transformation.
- →There is a clear emphasis on Make in India initiatives targeting government business and international penetration.
- →The company remains debt-free with a strong balance sheet, providing flexibility for ongoing investments in R&D and market expansion.
- →No explicit mention of specific current or future capex figures, but the strategic roadmap highlights continual investment in product innovation and global growth.
How does Quick Heal Technologies Ltd rank vs peers in IT - Software?
Pro feature1Quick Heal Technologies Ltd
Rev 3Mar 3
See full IT - Software sector rankings
How does Quick Heal Technologies Ltd rank in IT - Software?
Compare Quick Heal Technologies Ltd against every IT - Software company (Q4 FY26) on revenue, margins and earnings-call signals.